Compare NEA & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NEA | PBH |
|---|---|---|
| Founded | 2002 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.0B |
| IPO Year | N/A | 2005 |
| Metric | NEA | PBH |
|---|---|---|
| Price | $11.57 | $62.05 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $86.40 |
| AVG Volume (30 Days) | ★ 803.4K | 452.7K |
| Earning Date | 01-01-0001 | 02-05-2026 |
| Dividend Yield | ★ 4.23% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 4.04 |
| Revenue | N/A | ★ $1,110,479,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.50 |
| P/E Ratio | ★ N/A | $15.32 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.20 | $57.25 |
| 52 Week High | $11.37 | $90.04 |
| Indicator | NEA | PBH |
|---|---|---|
| Relative Strength Index (RSI) | 51.32 | 57.98 |
| Support Level | $11.45 | $60.98 |
| Resistance Level | $11.65 | $62.92 |
| Average True Range (ATR) | 0.09 | 1.45 |
| MACD | -0.00 | 0.28 |
| Stochastic Oscillator | 47.16 | 79.70 |
Nuveen AMT-Free Municipal Income Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax and the alternative minimum tax applicable to individuals, by investing in an actively managed portfolio of tax-exempt municipal securities. The company invest in Transportation, Utilities, Healthcare, Education and Civics, and other sectors, with maximum investment in Transportation.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.